AI Driven Patient Journey Mapping for Enhanced Engagement and Outcomes

Introduction

This workflow outlines the integration of AI-driven technologies in patient journey mapping and targeting, focusing on enhancing patient engagement and outcomes through data collection, segmentation, journey mapping, predictive analytics, personalized strategies, execution, and continuous optimization.

AI-Driven Patient Journey Mapping and Targeting Workflow

1. Data Collection and Integration

The process begins with gathering diverse data sources:

• Electronic Health Records (EHRs)
• Claims data
• Prescription data
• Patient-reported outcomes
• Social media data
• Wearable device data

AI tools, such as IQVIA’s Patient Journey software, can be utilized to integrate and analyze this data. This software applies AI to real-world data (RWD) to characterize approximately 300 million patients in real-time.

2. Patient Segmentation

AI algorithms are employed to segment patients into distinct groups based on:

• Demographics
• Clinical characteristics
• Behaviors
• Preferences
• Risk profiles

Tools that can be integrated at this stage include:

• 3M Clinical Risk Groups (CRGs): Utilizes AI to segment patients into 272 groups for detailed risk analysis.
• Johns Hopkins Adjusted Clinical Groups System: Provides AI-powered Patient Need Groups (PNGs) to segment individuals based on health needs and behaviors.

3. Journey Mapping

For each patient segment, AI is utilized to map the detailed patient journey:

• Analyze touchpoints across the care continuum
• Identify key decision points and influencers
• Uncover pain points and unmet needs

ZS Wayfinder is an example of an AI-powered application that can be integrated at this stage. It employs deep learning algorithms on real-world data to uncover patient pathways and dominant progression patterns.

4. Predictive Analytics

AI models are then applied to predict future patient behaviors and outcomes:

• Likelihood of adherence
• Risk of complications or hospitalizations
• Probability of switching treatments

IQVIA’s AI-driven HCP & Patient Profiling solution can be integrated at this stage to uncover patterns, trends, and key areas for advancing patient care.

5. Personalized Targeting and Engagement Strategy

Based on the journey mapping and predictive analytics, AI is employed to develop tailored engagement strategies:

• Personalize messaging and content
• Optimize channel selection
• Determine ideal timing of interventions

Artera’s AI-powered patient engagement platform can be integrated here to design unique care plans or service packages for each patient segment.

6. Execution and Automation

AI-powered tools are utilized to execute the personalized strategies:

• Automated messaging through preferred channels
• AI chatbots for patient support
• Smart scheduling of interventions

CRA’s AI/ML models for predictive modeling can be integrated to automate the identification of high-value customer segments and optimize engagement.

7. Continuous Monitoring and Optimization

AI algorithms continuously analyze engagement data to:

• Measure the effectiveness of interventions
• Identify new patterns or segments
• Refine targeting and engagement strategies

Eularis’ AI solutions can be integrated here to provide real-time insights and allow for continuous adjustment of strategies.

Improving the Workflow with AI in Customer Segmentation and Targeting

The integration of advanced AI in customer segmentation and targeting can significantly enhance this workflow:

1. Enhanced Segmentation: AI can create more granular and dynamic customer segments by analyzing a wider range of variables and identifying subtle patterns. For instance, IQVIA’s AI-driven solutions can segment patients based on not only clinical factors but also behavioral patterns and engagement preferences.
2. Real-time Personalization: AI enables real-time adaptation of patient journeys based on individual behaviors and interactions. ZS Wayfinder, for example, can automatically adjust patient journeys as patients engage with campaigns or complete visits.
3. Predictive Engagement: Advanced AI models can predict not only outcomes but also the best times and channels for engagement. This allows for proactive outreach before issues escalate. IQVIA’s solutions, for example, can predict when patients are most likely to need specific services.
4. Multi-dimensional Targeting: AI can simultaneously analyze HCP and patient data to identify optimal physician-patient matches for targeted interventions. CRA’s AI/ML models demonstrate this capability by jointly segmenting patient and HCP populations.
5. Automated Content Generation: AI can be utilized to automatically generate personalized content for different patient segments. This could include tailored educational materials or customized care plans.
6. Intelligent Resource Allocation: AI can optimize the allocation of resources (e.g., sales rep visits, marketing budget) across different patient segments based on predicted value and engagement potential.
7. Continuous Learning: Advanced AI models can continuously learn from new data, allowing for real-time refinement of segmentation and targeting strategies. Eularis’ AI solutions exemplify this capability by providing ongoing insights for strategy adjustment.

By integrating these AI-driven capabilities, healthcare and pharmaceutical companies can create a more dynamic, personalized, and effective patient journey mapping and targeting process. This leads to improved patient outcomes, increased adherence, and more efficient resource utilization.